$241 Million is the total value of SABBY MANAGEMENT, LLC's 89 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 115.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SECTOR HEALTHCAREput | $51,846,000 | – | 5,853 | +100.0% | 21.54% | – | |
| Sell | SPDR S&P 500 ETF TRput | $38,663,000 | -78.2% | 1,500 | -72.7% | 16.07% | -67.3% | |
| New | ISHARES RUSSELL 2000put | $23,556,000 | – | 2,058 | +100.0% | 9.79% | – | |
| Sell | SPDR GOLD TRUSTput | $20,668,000 | -16.8% | 1,396 | -19.7% | 8.59% | +24.7% | |
| Sell | SPDR GOLD TRUSTcall | $14,420,000 | -5.7% | 974 | -9.0% | 5.99% | +41.4% | |
| Buy | SPDR SERIES TRUSTput | $13,699,000 | +188.0% | 1,769 | +253.8% | 5.69% | +331.6% | |
| New | SECTOR HEALTHCAREcall | $8,858,000 | – | 1,000 | +100.0% | 3.68% | – | |
| Sell | SPDR S&P 500 ETF TRcall | $8,609,000 | -83.4% | 334 | -79.3% | 3.58% | -75.2% | |
| New | ISHARES NASDAQ BIOTECHput | $6,917,000 | – | 642 | +100.0% | 2.87% | – | |
| Sell | ISHARES RUSSELL 2000call | $4,407,000 | -79.5% | 385 | -70.3% | 1.83% | -69.3% | |
| XLV | New | SECTOR HEALTHCAREetf | $3,048,000 | – | 34,410 | +100.0% | 1.27% | – |
| New | GILEAD SCIENCES INCcall | $2,764,000 | – | 2,166 | +100.0% | 1.15% | – | |
| GLD | Sell | SPDR GOLD TRUST | $2,655,000 | -50.5% | 17,934 | -52.2% | 1.10% | -25.9% |
| New | CEL-SCI CORPput | $2,599,000 | – | 2,252 | +100.0% | 1.08% | – | |
| New | AVEO PHARMACEUTICALS INCput | $2,410,000 | – | 10,248 | +100.0% | 1.00% | – | |
| NOVN | New | NOVAN INC | $2,108,000 | – | 4,438,159 | +100.0% | 0.88% | – |
| ENLV | New | ENLIVEX THERAPEUTICS LTD | $2,086,000 | – | 445,673 | +100.0% | 0.87% | – |
| New | ISHARES NASDAQ BIOTECHcall | $2,036,000 | – | 189 | +100.0% | 0.85% | – | |
| OTLK | Buy | OUTLOOK THERAPEUTICS INC | $1,943,000 | +748.5% | 3,232,342 | +731.1% | 0.81% | +1181.0% |
| Buy | BRAINSTORM CELL INCput | $1,875,000 | +109.7% | 4,041 | +93.5% | 0.78% | +214.1% | |
| New | AVEO PHARMACEUTICALS INCcall | $1,531,000 | – | 4,229 | +100.0% | 0.64% | – | |
| ODT | Sell | ODONATE THERAPEUTICS INC | $1,353,000 | -22.6% | 48,988 | -9.0% | 0.56% | +16.1% |
| New | FIBROGEN INCput | $1,254,000 | – | 361 | +100.0% | 0.52% | – | |
| New | ODONATE THERAPEUTICS INCput | $1,229,000 | – | 445 | +100.0% | 0.51% | – | |
| New | TRILLIUM THERAPEUTICS | $1,163,000 | – | 287,906 | +100.0% | 0.48% | – | |
| New | BARCLAYS IPATHcall | $1,156,000 | – | 250 | +100.0% | 0.48% | – | |
| PAVMZ | Sell | PAVMED INC*w | $962,000 | +15.1% | 1,035,396 | -51.9% | 0.40% | +72.4% |
| BXRX | New | BAUDAX BIO INC | $927,000 | – | 373,977 | +100.0% | 0.38% | – |
| TTPH | New | TETRAPHASE | $854,000 | – | 667,000 | +100.0% | 0.36% | – |
| CTXR | New | CITIUS PHARMACEUTICALS | $813,000 | – | 1,354,275 | +100.0% | 0.34% | – |
| Buy | PLURISTEM THERAPEUTICSput | $768,000 | +8.5% | 2,093 | +16.5% | 0.32% | +62.8% | |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $757,000 | -32.0% | 440,274 | -18.2% | 0.32% | +1.9% |
| PSTI | Buy | PLURISTEM THERAPEUTICS | $705,000 | +217.6% | 192,049 | +240.3% | 0.29% | +372.6% |
| BPTH | Buy | BIO PATH HLDGS INC | $694,000 | -29.6% | 154,290 | +25.1% | 0.29% | +5.5% |
| IWM | New | ISHARES RUSSELL 2000etf | $675,000 | – | 5,900 | +100.0% | 0.28% | – |
| CVM | New | CEL-SCI CORP | $635,000 | – | 55,035 | +100.0% | 0.26% | – |
| New | TRANSENTERIX INC | $619,000 | – | 1,760,262 | +100.0% | 0.26% | – | |
| AUPH | New | AURINIA PHARMACEUTICALS | $617,000 | – | 42,500 | +100.0% | 0.26% | – |
| AMRN | Buy | AMARIN CORP PLCadr | $600,000 | +4.3% | 150,000 | +459.5% | 0.25% | +56.6% |
| Buy | ORAMED PHARMS INCput | $550,000 | -31.6% | 1,809 | +15.8% | 0.23% | +2.7% | |
| SRNE | Buy | SORRENTO THERAPEUTICS | $529,000 | +475.0% | 287,386 | +957.4% | 0.22% | +746.2% |
| PHIO | New | PHIO PHARMACEUTICALS | $452,000 | – | 255,194 | +100.0% | 0.19% | – |
| Buy | AURINIA PHARMACEUTICALScall | $448,000 | -24.1% | 309 | +6.2% | 0.19% | +13.4% | |
| AVEO | New | AVEO PHARMACEUTICALS INC | $406,000 | – | 112,155 | +100.0% | 0.17% | – |
| New | TRILLIUM THERAPEUTICScall | $404,000 | – | 1,000 | +100.0% | 0.17% | – | |
| PTE | New | POLARITYTE INC | $377,000 | – | 349,358 | +100.0% | 0.16% | – |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS | $356,000 | -38.2% | 107,577 | +14.0% | 0.15% | -7.5% |
| Sell | SORRENTO THERAPEUTICSput | $289,000 | -75.4% | 1,569 | -54.8% | 0.12% | -63.1% | |
| COCP | New | COCRYSTAL PHARMA INC | $278,000 | – | 392,206 | +100.0% | 0.12% | – |
| ASTC | New | ASTROTECH CORP NEW | $259,000 | – | 99,667 | +100.0% | 0.11% | – |
| SEEL | New | SEELOS THERAPEUTICS INC | $249,000 | – | 508,000 | +100.0% | 0.10% | – |
| HSDT | New | HELIUS MEDICAL | $246,000 | – | 746,316 | +100.0% | 0.10% | – |
| TEUM | New | PARETEUM CORP | $236,000 | – | 572,271 | +100.0% | 0.10% | – |
| AVGR | New | AVINGER INC | $236,000 | – | 568,400 | +100.0% | 0.10% | – |
| Sell | NABRIVA THERAPEUTICS PLC | $211,000 | -84.6% | 367,613 | -64.5% | 0.09% | -76.8% | |
| New | GENOCEA BIOSCIENCES INCcall | $207,000 | – | 1,201 | +100.0% | 0.09% | – | |
| New | TRILLIUM THERAPEUTICSput | $182,000 | – | 451 | +100.0% | 0.08% | – | |
| MYO | New | MYOMO INC | $184,000 | – | 51,588 | +100.0% | 0.08% | – |
| New | ALTIMMUNE INCput | $171,000 | – | 534 | +100.0% | 0.07% | – | |
| HEPA | New | HEPION PHARMACEUTICALS | $128,000 | – | 72,575 | +100.0% | 0.05% | – |
| Sell | OBALON THERAPEUTICS INC | $124,000 | -88.6% | 172,389 | -69.8% | 0.05% | -82.7% | |
| ATNM | Sell | ACTINIUM PHARMACEUTICALS | $121,000 | -83.0% | 621,840 | -81.0% | 0.05% | -74.7% |
| Buy | AKERS BIOSCIENCES INC | $118,000 | +26.9% | 55,400 | +90.4% | 0.05% | +88.5% | |
| ZSAN | New | ZOSANO PHARMA CORP | $114,000 | – | 203,536 | +100.0% | 0.05% | – |
| New | APPLIED DNA SCIENCES INC | $106,000 | – | 26,397 | +100.0% | 0.04% | – | |
| New | GENPREX INCput | $107,000 | – | 441 | +100.0% | 0.04% | – | |
| RWLK | Buy | REWALK ROBOTICS LTD | $99,000 | -63.7% | 229,699 | +81.9% | 0.04% | -46.1% |
| NURO | Buy | NEUROMETRIX INC | $93,000 | -66.2% | 82,250 | +28.8% | 0.04% | -48.7% |
| EFOI | New | ENERGY FOCUS INC | $88,000 | – | 267,298 | +100.0% | 0.04% | – |
| New | BELLICUM PHARMACEUTICALS | $89,000 | – | 18,927 | +100.0% | 0.04% | – | |
| BNTC | Sell | BENITEC BIOPHARMA LTDads | $85,000 | -85.9% | 21,592 | -81.7% | 0.04% | -79.0% |
| SNCA | Sell | SENECA BIOPHARMA INC | $76,000 | -79.9% | 115,311 | -69.8% | 0.03% | -69.5% |
| Sell | AMARIN CORP PLCcall | $75,000 | -98.3% | 188 | -90.8% | 0.03% | -97.4% | |
| BLIN | BRIDGELINE DIGITAL INC | $73,000 | -56.8% | 110,000 | 0.0% | 0.03% | -36.2% | |
| EARS | Sell | AURIS MEDICAL HOLDING | $72,000 | -74.1% | 89,451 | -48.0% | 0.03% | -61.0% |
| New | INVIVO THERAPEUTICS | $55,000 | – | 32,660 | +100.0% | 0.02% | – | |
| XBIO | Sell | XENETIC BIOSCIENCES INC | $45,000 | -88.2% | 60,523 | -77.2% | 0.02% | -82.1% |
| SHIPZ | Sell | SEANERGY MARITIME*w | $45,000 | -55.0% | 897,499 | -1.2% | 0.02% | -32.1% |
| ADMP | New | ADAMIS PHARMACEUTICALS | $32,000 | – | 88,210 | +100.0% | 0.01% | – |
| New | ACELRX PHARMS INCput | $26,000 | – | 220 | +100.0% | 0.01% | – | |
| SYN | Sell | SYNTHETIC BIOLOGICS INC | $25,000 | -92.8% | 76,896 | -88.8% | 0.01% | -89.6% |
| MDGSW | Sell | MEDIGUS LTD*w | $22,000 | -76.3% | 1,007,444 | -0.1% | 0.01% | -65.4% |
| New | PARETEUM CORPput | $21,000 | – | 572 | +100.0% | 0.01% | – | |
| Sell | TENAX THERAPEUTICS INC | $19,000 | -68.9% | 32,842 | -23.9% | 0.01% | -52.9% | |
| RBZHF | REEBONZ HOLDING LTD | $10,000 | -65.5% | 25,000 | 0.0% | 0.00% | -50.0% | |
| NSPR | Sell | INSPIREMD INC | $7,000 | -97.4% | 11,036 | -95.6% | 0.00% | -96.0% |
| SINT | New | SINTX TECHNOLOGIES INC | $7,000 | – | 18,272 | +100.0% | 0.00% | – |
| New | INTEC PHARMA LTDcall | $3,000 | – | 175 | +100.0% | 0.00% | – | |
| CNBX | New | CANNABICS | $1,000 | – | 7,286 | +100.0% | 0.00% | – |
| Exit | ADAMIS PHARMACEUTICALS CORPput | $0 | – | -111 | -100.0% | -0.00% | – | |
| SHIP | Exit | SEANERGY MARITIME HOLDINGS CORP | $0 | – | -49,999 | -100.0% | -0.01% | – |
| SNES | Exit | SENESTECH INC | $0 | – | -48,294 | -100.0% | -0.01% | – |
| Exit | CELSION CORPput | $0 | – | -184 | -100.0% | -0.01% | – | |
| SPHS | Exit | SOPHIRIS BIO INC | $0 | – | -42,378 | -100.0% | -0.02% | – |
| ALT | Exit | ALTIMMUNE INC COM | $0 | – | -44,855 | -100.0% | -0.02% | – |
| AEZS | Exit | AETERNA ZENTARIS INC | $0 | – | -101,976 | -100.0% | -0.03% | – |
| VBLT | Exit | VASCULAR BIOGENICS LTD | $0 | – | -80,295 | -100.0% | -0.03% | – |
| CLSN | Exit | CELSION CORP | $0 | – | -68,560 | -100.0% | -0.03% | – |
| GNPX | Exit | GENPREX INC | $0 | – | -443,441 | -100.0% | -0.04% | – |
| LPCN | Exit | LIPOCINE INC | $0 | – | -367,693 | -100.0% | -0.04% | – |
| DMPI | Exit | DELMAR PHARMACEUTICALS INC | $0 | – | -1,226,022 | -100.0% | -0.04% | – |
| Exit | VIKING THERAPEUTICS INCcall | $0 | – | -200 | -100.0% | -0.04% | – | |
| OGEN | Exit | ORAGENICS INC | $0 | – | -351,045 | -100.0% | -0.05% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -60,361 | -100.0% | -0.06% | – |
| Exit | AVEO PHARMACEUTICALS INCcall | $0 | – | -3,625 | -100.0% | -0.06% | – | |
| AIM | Exit | AIM IMMUNOTECH INC | $0 | – | -528,811 | -100.0% | -0.08% | – |
| XBIOW | Exit | XENETIC BIOSCIENCES INC*w | $0 | – | -216,789 | -100.0% | -0.08% | – |
| PULM | Exit | PULMATRIX INC | $0 | – | -446,749 | -100.0% | -0.11% | – |
| GHSI | Exit | GUARDION HEALTH SCIENCES INC | $0 | – | -1,993,929 | -100.0% | -0.12% | – |
| Exit | DIFFUSION PHARMACEUTICALS INC | $0 | – | -1,085,446 | -100.0% | -0.14% | – | |
| INNT | Exit | INNOVATE BIOPHARMACEUTICLS INC | $0 | – | -941,586 | -100.0% | -0.15% | – |
| PSTV | Exit | PLUS THERAPEUTICS INC | $0 | – | -234,124 | -100.0% | -0.16% | – |
| Exit | TOP SHIPS INC | $0 | – | -799,212 | -100.0% | -0.18% | – | |
| Exit | AVEO PHARMACEUTICALS INCput | $0 | – | -10,851 | -100.0% | -0.19% | – | |
| Exit | MICROBOT MED INC | $0 | – | -76,000 | -100.0% | -0.21% | – | |
| Exit | BIOGEN INCcall | $0 | – | -28 | -100.0% | -0.23% | – | |
| Exit | ARQULE INC COMcall | $0 | – | -772 | -100.0% | -0.43% | – | |
| ONTX | Exit | ONCONOVA THERAPEUTICS INC | $0 | – | -8,741,243 | -100.0% | -0.93% | – |
| Exit | SPDR S&P BIOTECHcall | $0 | – | -385 | -100.0% | -1.02% | – | |
| Exit | AMARIN CORP PLCput | $0 | – | -2,046 | -100.0% | -1.22% | – | |
| Exit | IONIS PHARMACEUTICALS INCcall | $0 | – | -2,961 | -100.0% | -4.96% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.